IRIS
TROVATO, Maria Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.424
NA - Nord America 3.423
AS - Asia 2.156
SA - Sud America 770
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 10.853
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.378
RU - Federazione Russa 2.109
SG - Singapore 951
BR - Brasile 671
CN - Cina 648
IE - Irlanda 533
SE - Svezia 524
FR - Francia 291
UA - Ucraina 252
HK - Hong Kong 243
DE - Germania 236
IT - Italia 190
FI - Finlandia 119
VN - Vietnam 99
GB - Regno Unito 88
IN - India 43
AR - Argentina 42
BD - Bangladesh 22
TR - Turchia 22
MA - Marocco 20
BE - Belgio 18
CA - Canada 16
IQ - Iraq 16
MX - Messico 16
ZA - Sudafrica 14
EC - Ecuador 11
ID - Indonesia 11
NL - Olanda 11
VE - Venezuela 11
JP - Giappone 10
UZ - Uzbekistan 10
CO - Colombia 9
PK - Pakistan 8
AZ - Azerbaigian 7
CL - Cile 7
CZ - Repubblica Ceca 7
EG - Egitto 7
ES - Italia 7
SA - Arabia Saudita 7
AL - Albania 6
IR - Iran 6
JO - Giordania 6
UY - Uruguay 6
IL - Israele 5
KE - Kenya 5
PY - Paraguay 5
RO - Romania 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CI - Costa d'Avorio 4
DZ - Algeria 4
EU - Europa 4
KR - Corea 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
PE - Perù 4
TN - Tunisia 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
NP - Nepal 3
PH - Filippine 3
PS - Palestinian Territory 3
SN - Senegal 3
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
ET - Etiopia 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
MM - Myanmar 2
MN - Mongolia 2
PA - Panama 2
PL - Polonia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 10.849
Salva come PNG Salva come JPEG
Città #
Moscow 620
Dublin 532
Singapore 512
Jacksonville 496
Ashburn 410
Chandler 351
Dallas 264
Beijing 257
Hong Kong 243
Nyköping 243
The Dalles 108
Princeton 100
Cambridge 97
Lauterbourg 95
Ann Arbor 86
Medford 85
San Jose 84
Los Angeles 74
Des Moines 69
Dearborn 60
Messina 50
Boardman 44
Buffalo 41
Munich 37
São Paulo 36
Wilmington 34
Ho Chi Minh City 33
Woodbridge 31
Bremen 29
Redondo Beach 29
New York 28
Jinan 27
Nanjing 23
San Mateo 23
Council Bluffs 22
Guangzhou 22
Rio de Janeiro 21
Tianjin 21
Belo Horizonte 20
Hanoi 19
Mazzarra Sant'andrea 19
Brussels 18
Houston 17
Shenyang 16
Turku 16
Lancaster 15
Seattle 15
Brasília 14
Falls Church 14
Santa Clara 14
Hangzhou 12
Orem 12
Taizhou 12
Shanghai 10
Tokyo 10
Zhengzhou 10
Chennai 9
Curitiba 9
Haikou 9
Helsinki 9
London 9
Ribeirão Preto 9
Baghdad 8
Chicago 8
Frankfurt am Main 8
Hillsboro 8
San Francisco 8
Sorocaba 8
Tashkent 8
Acireale 7
Brooklyn 7
Clearwater 7
Fuzhou 7
Gravataí 7
Hebei 7
Ningbo 7
Auburn Hills 6
Baku 6
Changsha 6
Denver 6
Haiphong 6
João Pessoa 6
Nova Iguaçu 6
Porto Alegre 6
Rome 6
Salvador 6
São José dos Campos 6
Atlanta 5
Betim 5
Buenos Aires 5
Cairo 5
Campinas 5
Carapicuíba 5
Casablanca 5
Fortaleza 5
Guarulhos 5
Hyderabad 5
Istanbul 5
Lahore 5
Leawood 5
Totale 5.890
Salva come PNG Salva come JPEG
Nome #
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 202
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 189
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 183
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 183
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 176
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 176
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 176
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 167
Realtà complesse ed epidemiologia di un fenomeno 166
Expression of NA/1 symporter (NIS) in endometrial mucosa of fertile, sterile and post-menopausal women. 162
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 160
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 157
APLOTIPI DEL MICROSATELLITE D7S6440 INTERNO AL GENE HIPK2 COME MARCATORI DELLA TIROIDE AUTOIMMUNITARIA 156
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 153
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 150
Cellule giganti tipo corpo estraneo nel carcinoma papillare della tiroide 150
Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology 150
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 149
Deposito presso la GenBank della sequenza genica del microsatellite di 360 bp denominato “D7S6440”, trovato nell’Homo sapiens, localizzato nel cromosoma 7q 32-34, all’interno del gene HIPK2, a livello dell’introne 9; con tandem di ripetizione fra 173..198 bp costituito da sequenze “ca”. 146
Cancer Thyroid Nodule: Knowing is Doing 146
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 142
Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas 139
HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization 139
CD£0 ligand (CD30L)/CD30 receptor (CD30) signaling in benign and malignant thyroid nodules 138
Compared with healthy controls, serum hepatocyte growth factor (HGF) is increased in the nodular variant of Hashimoto's thyroiditis (HT) more than in the nonnodular variant, whereas serum interleukin-6 (IL-6) is increased regardless of associated thyroid nodules. 138
Cell-type specifc loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 137
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules. 130
Ultrastructural findings of thyrocytes are signatures for an accurate interpretation of cytological aspirates 130
Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals 129
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules: possible implications for pharmachologic treatment of the differentiated thyroid cancer (DTC). 128
Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules 127
Compendio di Anatomia Patologica 125
The new era of vaccines: the “nanovaccinology” 125
EGF, TGF-alpha, EGF receptor (EGFR) and somatostatin receptors 2 (SSR2) in acanthosis nigricans (AN) 115
Thyroid hemiagenesis, Graves' disease and differentiated thyroid cancer: a very rare association: case report and review of literature 115
The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization. 110
Espressione di CD30 e CD30 ligando nelle decidue di aborti spontanei 108
Immunoexpression of CD30 and CD30 ligand in deciduas from spontaneous abortions 108
What is New on Thyroid Cancer Biomarkers 107
STAT3 is selectively expressed in papillary thyroid cancer (PTC) and some follicular adenomas 106
TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto's thyroiditis 106
Multidrug resistance protein 2 (MRP2) nei carcinomi midollari della tiroide 105
Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up 105
Multidrug-resistance protein 2 (MRP-2) expression in medullary thyroid carcinoma. 104
LACK OF SOMATOSTATIN ANALOGS (SSAS) EFFECTIVENESS IN GONADOTROPIN-SECRETING PITUITARY ADENOMAS: REPORT OF A CASE AND A REVIEW OF THE LITERATURE 103
Immunoexpression of the hepatocyte growth factor (HGF), HGF- receptor (c-met) and STAT3 on placental tissues from malformed fetuses 101
Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer 100
Espressione del CDX2 nelle varie fasi dello sviluppo placentare 99
Perdita di eterozigosi su 7q21 nella patologia multinodulare della tiroide 98
New Research Communication on Thyroid Tumor Markers 97
METODO PER LA DIAGNOSI IN VITRO DI CARCINOMA TIROIDEO 96
Nanostructures: between natural environment and medical practice. 96
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. 95
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 94
Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions 93
Multidrug resistance protein-2 (MRP-2) nel carcinoma midollare della tiroide. 93
L'espressione di STAT3 èpiù frequentemente associata al sistema HGF7c-met rispetto ad IL-6/IL6R nei carcinomi papillari e negli adenomi follicolari tiroidei 92
The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas 91
Distinctive expression of STAT3 in papillary thyroid carcinoma and a subset of follicular adenomas. 90
Expression of transcription factor STAT3 associated to HGF/c-met system in normal and pathological thyroid tissue. 90
Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated p53 Is Required for p53-Induced Apoptosis. 90
EGF, TGFA-apla, EGF receptor (EGFR) and somatostatin receptors (SSR2) in acanthosis nigricans (AN) 89
Espressione immunoistochimica di HGF, c-met e STAT3 in placente da gravidanze con feti malformati 89
La perdita di eterozigosità (LOH) per markers sul braccio lungo del cromosoma 7 (7q) è peculiare dei carcinomi tiroidei follicolari (FTC) e anaplastici (ATC), non dei papillari (PTC). 88
LOH sul braccio lungo del cromosoma 7 è una frequente alterazione genetica nel carcinoma follicolare ed anaplastico della tiroide. 88
Loss of heterozygosity for 7q21.1 and 31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancers 88
Prognostic and predictive biomarkers in thyroid diseases: “magic bullets” for a personalized therapeutic strategy 88
Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas 86
SELECTIVE RADIO-GUIDED NECK DISSECTION FOR CERVICAL LYMPH NODE METASTASIS FROM OCCULT THYROID CANCER: REPORT OF A CASE 85
MULTIDRUG-RESISTANCE PROTEIN 2 (MRP2) E CICLO-OSSIGENASI 2 (COX2) NEL CARCINOMA MIDOLLARE DELLA TIROIDE. 84
New Research Communication on Thyroid Tumor Markers 84
Hepatocyte growth factor (HGF) expression and circulating levels in nodular Hashimoto's thyroiditis. 83
Immunodimostrazione dell'antigene K-1 (CD30) nella patologia autoimmune e neoplastica della tiroide. 82
THE LOSS OF THE P53 ACTIVATOR HIPK2 IS RESPONSIBLE FOR GALECTIN-3 OVEREXPRESSIONIN WELL DIFFERENTIATED THYROID CARCINOMAS 82
Espressione genica della via p53/HGF/c-met /STAT3 nei feti con malformazioni del sistema nervoso. 81
Expression of transcription factor STAY3 associated to HGF/c-met and IL-6/IL-6r sistems in normal and pathologic thyroid tissue 80
Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases 80
Espressione dei fattori della morfogenesi negli organi e nelle placente di feti a varie epoche di gestazione 79
Loss of heterozygosity of 7q21.1 and 7q31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancer. 79
Expression of IL6/IL6R and CD30L/C30 in normal thyroid and thyroid nodules. 79
Interleukin‑6 signalling as a valuable cornerstone for molecular medicine 78
Hepatocyte growth factor (HGF) expression in nodular Hashimoto thyroditis. 77
Serum Levels And Immohistochemical Expression Of Hepatocyte Growth Factor (Hgf) in Hashimoto Thyroiditis 76
Serum levels and immunochemical expression of hepatocyte growth factor (HGF) in Hashimoto's thyroiditis. 76
The use of Laser Capture Microdissection in the identification of new putative oncosoppressor genes in thyroid cancer. 76
EXPRESSION IN DECIDUAL SAMPLES OF SPONTANEOUS ABORTIONS. 76
Serum levels and immunohistochemical expression of Hepatocyte Growth Factor (HGF) in Hashimoto thyroiditis. 74
Espressione dlel'hepatocyte growth factor (HGF) e del suo recettore (HGF-R o c-met) nei carcinomi papillari tiroidei. 74
Serum Amyloid A (SAA) expression by medullary thyroid cancer (MTC). 74
Polimorfismo dle gene TP53 nrlla tiroidite di Hashimoto (TH). 72
Single Nucleotide Polymorphisms (SNPs) in exon 4 of p53 as genetic markers of susceptibility for Hashimoto’s thyroiditis (HT) 71
Expression of HGF and HGF-receptor (c-met) in the papillary thyroid cancer (PTC). 70
Serum amyloid A (SAA) expression in medullary thyroid cancer (MTC). 69
Dimostrazione immunocitochimica dell'Hepatocyte Growth Factor (HGF) e del suo recettore c-met nel tessuto tiroideo normale e patologico. 68
Immunohistochemical expression of HGF, c-met and transcription-factor STAT3 in colorectal tumors. 68
Expression of p53/ HGF/c-met/ STAT3 signal in fetus with malformation of nervous system. 66
Papillary and follicular thyroid carcinomas show LOH in two distinct regions of the long arm of chromosome 7 64
Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects 62
Specific haplotypes of a microsatellite markers internal to the HIPK2 gene in Hashimoto thyroditis 61
Totale 10.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 65 59 28
2021/2022683 6 86 20 34 31 7 44 32 14 110 103 196
2022/20231.524 123 107 64 102 123 171 16 94 653 3 55 13
2023/2024332 31 60 31 46 39 48 4 34 0 7 2 30
2024/20251.732 15 32 35 115 73 80 16 421 441 80 107 317
2025/20264.516 222 311 278 295 430 1.117 570 553 592 148 0 0
Totale 10.961